DEF 14ATELACIK 0001561921

TELA Bio, Inc.

Name: SEC EDGAR filing 0001104659-26-053117
Creator: TELA Bio, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed April 30, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Filing facts

Accession number: 0001104659-26-053117
Filer: TELA Bio, Inc.
Ticker: TELA
CIK: 0001561921
Form type: DEF 14A
Form description: Proxy statement
Filed at: April 30, 2026
Industry: SIC 3841Surgical & Medical Instruments
Last verified: May 1, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1561921/000110465926053117/0001104659-26-053117-index.htm ↗

Filer's full EDGAR submission history

EDGAR · TELA Bio, Inc. (0001561921) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001104659-26-053117.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.